Cancer Treatment Strategy Depending on CRISPR Technology

Authors

  • Tiancong Du

DOI:

https://doi.org/10.61173/pdekfk57

Keywords:

CRISPR, Cas9, gRNA, CAR-T, lncRNA

Abstract

Cancer keeps posing a major threat to human health all over the word. CRISPR technology is an emerging gene editing technique, which offers new ideas for cancer treatment. Compared with traditional therapies including surgery, radiotherapy, and chemotherapy, it has many advantages such as complete cure, high precision, efficiency, and low side effects. The CRISPR system mainly consists of Cas9 and gRNA, of which gRNA helps recognize specific DNA sequences and guides the Cas9 protein to cleavage doublestrand. Subsequently, genetic mutations are produced in the process of repair mechanisms. CRISPR therapy for cancer has two main approaches, that are modifying immune cells and editing the genes of cancer cells. This article focused on CRISPR-based CAR-T technology to enhance their ability to recognize and destroy tumor cells. Another strategy directly targets cancer genomes, disabling oncogenes or restoring the function of tumorsuppressor genes. Despite these promising advances, several limitations of CRISPR-based technology remain including off-target effects, reducing editing efficiency, in vivo immune reactions to Cas proteins. Therefore, CRISPR-Cas9 is a versatile and powerful tool for advancing precision oncology, contributing to future clinical applications of more effective, gene-based cancer treatments.

References

Even if the editing is successful, the success rate is not Science and Technology, 2024, 92: 105338. 100%, which will cause the target protein to lose its func- [2] Hao J R, Wang S X. (2021). Research Progress on the tionality significantly and significantly reduce the thera- Application of CRISPR/Cas9 Technology in Disease Treatment.

peutic effect. How to improve the accuracy and efficiency Journal of MuDanJiang Medical University, 2021,42(06):130- of CRISPR while avoiding off-target effects needs to be 132. overcome. In addition to the off-target problem, Cas9, as a [3] Niu Y M, Wang Y N, Zhang Y. Research progress of foreign bacterial protein, may trigger an immune response CRISPR/Cas9 technology in endometrial cancer treatment. Dean&Francis Tiancong Du

Modern Oncology, 2025,33(02):321-326. cells against lung cancer. Chinese Journal of Gerontology, [4] Xue C, Greene E C. DNA repair pathway choices in 2023,43(14):3483-3487. CRISPR-Cas9-mediated genome editing. Trends in Genetics, [8] Li X, Hu Y, Wang Y M. CRISPR/Cas9 Technology: 2021, 37(7): 639-656. Exploring the Functions of IncRNAs and Their Roles in Cancer [5] Wu Q, Wang S B. Progress in CRISPR/Cas9 for CAR-T Progression. Chinese Journal of Biochemistry and Molecular

cell therapy of tumors. Basic and Clinical Medicine, Biology, 2025,41(03):364-375. 2023,43(08):1313-1316. [9] Carlos D, Raquel A, Henrique C, Thiago M, Tulio F, Ana [6] Medjebar S, Truntzer C, Perrichet A, et al. Angiotensin- C, Mari C. Functional impact of the long non‑coding RNA converting enzyme (ACE) inhibitor prescription affects non- MEG3 deletion by CRISPR/Cas9 in the human triple negative small-cell lung cancer (NSCLC) patients response to PD-1/PD- metastatic Hs578T cancer cell line. Oncology letters, 2019,

L1 immune checkpoint blockers. Oncoimmunology, 2020, 9(1): 18(6): 5941-5951. 1836766. [10] Liu J, Zheng J M. Applications and Prospects of CRISPR- [7] Jiang W H, Gao Y S, Liu N, Zhang Y, Yang Y J, Wang G Cas9 Gene Editing Technology. Chinese Journal of Chemical

G, Dong Y H, Zhang Z M. CRISPR/Cas9 knockout of PD-1 Education, 2025,46(04):1-8. effectively enhances the antitumor activity of EGFR-CAR-T

Downloads

Published

2025-12-19